SUSTAINABILITY

STRATEGIES TO ACHIEVE LONG-TERM SUSTAINABILITY

STRATEGIES TO ACHIEVE LONG-TERM SUSTAINABILITY

Peter Soelkner and Thomas Otto discuss how the pharmaceutical service provider focuses on sustainability.

PLASMA TECHNOLOGY – THE FUTURE OF RESPIRATORY DEVICES

Jacqueline Green

PLASMA TECHNOLOGY – THE FUTURE OF RESPIRATORY DEVICES

Jacqueline Green discusses how H&T Presspart’s plasma treatment process can provide a future-proof and sustainable solution for some of the issues associated with suspension formulations in the respiratory device industry.

SUSTAINABILITY, WASTE & REMANUFACTURING IN THE MEDICAL SECTOR

SUSTAINABILITY, WASTE & REMANUFACTURING IN THE MEDICAL SECTOR

Cormac O’Prey discusses some of the sustainability challenges facing the medical sector, such as how to make re-use and remanufacturing viable for high-volume, low-value products, and how answers can be found by looking to successful solutions deployed by other industries.

SUSTAINABILITY WITH THE ARIA AUTOINJECTOR: A LIFECYCLE ASSESSMENT

Phillips Medisize

SUSTAINABILITY WITH THE ARIA AUTOINJECTOR: A LIFECYCLE ASSESSMENT

Emil Fraenkel and Bjarne Sørensen consider the sustainability of re-usable and disposable autoinjectors, its implications in adding connectivity to drug delivery devices and how it has been an important consideration for Phillips-Medisize in the development of the Aria re-usable autoinjector.

PHARMAPACK EUROPE DRUG DELIVERY AND PACKAGING ANNUAL SURVEY 2021

PHARMAPACK EUROPE DRUG DELIVERY AND PACKAGING ANNUAL SURVEY 2021

Pharmapack presents the results of its annual survey and market report, covering the latest Pharmapack Innovation Index and the inaugural Pharmapack Sustainability Index, and taking stock of where the survey results suggest the pharma industry currently is, and where it is heading, in terms of innovation and sustainability.

DATA-DRIVEN SUSTAINABILITY IN AUTOINJECTOR DEVELOPMENT

Frederick Gertz

DATA-DRIVEN SUSTAINABILITY IN AUTOINJECTOR DEVELOPMENT

Frederick Gertz and Yves Steffen outline the company’s approach to sustainability, involving leveraging the experience of its data science department to enhance the output of its sustainability department.

FORMULATION DEVELOPMENT AND DRUG DELIVERY: JOINED AT THE DEVICE

Julie Cotterell

FORMULATION DEVELOPMENT AND DRUG DELIVERY: JOINED AT THE DEVICE

Julie Cotterell discusses the major factors at play driving the direction of innovation in the subcutaneous drug delivery space, with a particular emphasis on the push towards patient self-administration.

IMPORTANT CONSIDERATIONS WHEN DESIGNING FOR SUSTAINABILITY

Mr Michael Kiely

Jabil Healthcare

IMPORTANT CONSIDERATIONS WHEN DESIGNING FOR SUSTAINABILITY

Michael Kiely, Gerard Linnane and Justin Carroll discuss how implementing a thoughtful design-for-sustainability process can ensure medical devices not only improve patients’ lives but are also kinder to the environment.

EIGHT ESSENTIAL SUSTAINABILITY TERMS FOR THE MEDICAL DEVICE INDUSTRY

EIGHT ESSENTIAL SUSTAINABILITY TERMS FOR THE MEDICAL DEVICE INDUSTRY

Kay Sinclair, Brennan Miles and Charlie Dean provide an overview of eight terms key to a common understanding in the ongoing, and crucial, discussion surrounding sustainability.

HERE TODAY AND DEFINITELY NOT GONE TOMORROW: WHY SIMPLICITY AND EASE OF USE ARE THE KEY FOR A NEW GENERATION OF REUSABLE INJECTORS

Dr Kate Hudson-Farmer

Phillips Medisize

HERE TODAY AND DEFINITELY NOT GONE TOMORROW: WHY SIMPLICITY AND EASE OF USE ARE THE KEY FOR A NEW GENERATION OF REUSABLE INJECTORS

Kate Hudson-Farmer discusses how a new electronic reusable autoinjector – the Aria Smart Autoinjector from Phillips-Medisize – has been designed and user-tested to challenge the preconceived ease-of-use notions about electronic autoinjectors, in addition to addressing how macro trends and personal consumer subtleties could become increasingly important in creating a competitive position as devices seek to improve patient engagement.

HOSTAFORM<sup>®</sup> POM ECO-B – PROVEN, VERSATILE, EASY AND SUSTAINABLE

HOSTAFORM^® POM ECO-B – PROVEN, VERSATILE, EASY AND SUSTAINABLE

Kevin Norfleet and Rob Haley discuss the need for environmentally sustainable materials in the medical device industry, and how Celanese’s Hostaform^® MT^® POM ECO-B meets that need, being an exact equivalent to the company’s existing material but produced using up to 97% bio-content using a potential greenhouse gas as feedstock, accounted for using the mass balance approach.

INTRODUCING ISOSORBIDE: A SUSTAINABLE, SAFE, HIGH-PERFORMANCE, PLANT-BASED FEEDSTOCK FOR PACKAGING

INTRODUCING ISOSORBIDE: A SUSTAINABLE, SAFE, HIGH-PERFORMANCE, PLANT-BASED FEEDSTOCK FOR PACKAGING

Jiae Kim introduces isosorbide, a plant starch-derived diol made from renewable feedstock that has wide ranging applications across polymer materials for a variety of industries.

THE NEW EMERGING NEEDS DRIVING AUTOINJECTOR DEVELOPMENT

Dr Iain Simpson

Phillips Medisize

THE NEW EMERGING NEEDS DRIVING AUTOINJECTOR DEVELOPMENT

Iain Simpson discusses the emerging needs to be considered when bringing new autoinjector drug-device combinations to market.

FROM DESIGN TO DISPOSAL: ACHIEVING SUSTAINABILITY IN MEDICAL DEVICES

FROM DESIGN TO DISPOSAL: ACHIEVING SUSTAINABILITY IN MEDICAL DEVICES

George I’ons discusses the onus on the device design industry to move towards sustainable practices, including what this entails, how it might be achieved and what benefits sustainability may bring.

PHARMA’S ROLE IN THE GLOBAL ENVIRONMENTAL SUSTAINABILITY MOVEMENT

PHARMA’S ROLE IN THE GLOBAL ENVIRONMENTAL SUSTAINABILITY MOVEMENT

Alex Catino discusses current trends in the pharmaceutical industry in relation to environmental sustainability in healthcare.

SUSTAINABLE PHARMACEUTICALS CAN OUTPERFORM THROUGH NATURALLY DERIVED INGREDIENTS & DEEP EXPERTISE

SUSTAINABLE PHARMACEUTICALS CAN OUTPERFORM THROUGH NATURALLY DERIVED INGREDIENTS & DEEP EXPERTISE

Rina Chokshi discusses the benefits of naturally derived, sustainable ingredients and their benefits to the environment and pharmaceutical industry.

PRODUCT SHOWCASE: ZwickRoell Luer Lock Testing System

Wolfgang Moersch

PRODUCT SHOWCASE: ZwickRoell Luer Lock Testing System

Wolfgang Moersch provides an update on ZwickRoell's Luer Lock Testing System and describes the company's sustainability policies, it having been carbon neutral since 2014.

CUTTING CARBON IMPACT: CREATING A SUSTAINABLE pMDI COMPONENT SUPPLY CHAIN

CUTTING CARBON IMPACT: CREATING A SUSTAINABLE pMDI COMPONENT SUPPLY CHAIN

Wim Kehoe and Ameet Sule discuss H&T Presspart’s approach to sustainability, and the developments that are helping to reduce the carbon footprint of pMDIs.

LEADING PHARMACEUTICAL DEVELOPMENT IN A SUSTAINABLE WAY – SKYEPHARMA’S EXAMPLE

Dr Aline Moulin

Skyepharma Production

LEADING PHARMACEUTICAL DEVELOPMENT IN A SUSTAINABLE WAY – SKYEPHARMA’S EXAMPLE

Aline Moulin and Laurent Rigaudeau discuss how Skyepharma fulfils its sustainable development policy through its technologies and processes.

NANOTECHNOLOGY: A PATHWAY FOR SUSTAINABLE INNOVATION IN DRUG DEVELOPMENT

NANOTECHNOLOGY: A PATHWAY FOR SUSTAINABLE INNOVATION IN DRUG DEVELOPMENT

Andrea Cusack discusses how, by using bottom-up nanotechnology techniques, efficiencies can be found both in the development of new chemical entities and in the repurposing of existing drugs, and how these efficiencies translate into reduced energy requirements and therefore more sustainable industry practices.

INTERVIEW: ERIK HAEFFLER, RECIPHARM

INTERVIEW: ERIK HAEFFLER, RECIPHARM

In this interview, Erik Haeffler discusses how the pharma industry can balance optimising environmental sustainability with maintaining the highest safety and efficacy standard for achieving its main objective of promoting patient health and wellbeing.

SMART GOALS AND CONTINUOUS IMPROVEMENT FOR A RESILIENT SUSTAINABILITY STRATEGY

SMART GOALS AND CONTINUOUS IMPROVEMENT FOR A RESILIENT SUSTAINABILITY STRATEGY

Dirk Borghs considers the obligation of the pharmaceutical sector to implement environmentally responsible practices, and discusses the steps Datwyler is taking in its efforts for sustainability.

NEXT-GENERATION PMDIS: A HOLISTIC, PATIENT-CENTRED APPROACH TO SUSTAINABILITY

NEXT-GENERATION PMDIS: A HOLISTIC, PATIENT-CENTRED APPROACH TO SUSTAINABILITY

Mike Needham, Phil Cocks and Louise Righton discuss how sustainability should be a central theme of future innovation in inhalation drug delivery but must be balanced with the needs of the patient.

PAVING THE WAY TO ZERO CARBON EMISSION COMBINATION PRODUCTS: THE YPSOMATE ZERO CASE STUDY

Sebastian Gerner

PAVING THE WAY TO ZERO CARBON EMISSION COMBINATION PRODUCTS: THE YPSOMATE ZERO CASE STUDY

Sebastian Gerner and Andreas Schneider discuss the relationship between the medical device industry and the global issue of plastic waste. The authors introduce YpsoMate Zero as a case study, Ypsomed’s net-zero carbon emission prefilled autoinjector.

Prev
1
…
4
5
6
7
Next

Top